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1 Prof. Irith Ginzburg has deceased (July 21, 2008).BAG-1 protein has been well characterized as necessary for proper neuronal development. However,
little is known about the function of BAG-1 in the adult brain. In this work, the expression and local-
ization of BAG-1 in the mature mouse brain was studied. The levels of both BAG-1 isoforms decrease
signiﬁcantly in the brain during development. BAG-1 was found preferentially expressed in Neuro-
nal Precursor Cells (NPCs) in the two major niches of neurogenesis. Lentiviral mediated overexpres-
sion of BAG-1 increased the proliferation rate of cultured NPCs. In addition, depletion of BAG-1 from
NPCs induced a decrease in NPCs proliferation in the presence of a stress hormone, corticosterone.
These data suggest a role for BAG-1 in mechanisms of neurogenesis in the adult mouse brain.
 2008 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
BAG-1 protein is a multifunctional protein that plays signiﬁcant
roles in regulation of apoptosis, gene transcription, and cellular dif-
ferentiation. BAG-1 is expressed as three isoforms that all originate
from the samemessenger RNA by alternative start codons. Humans
express BAG-1L, BAG-1M, and BAG-1S, while mice only express
BAG-1L and BAG-1S [1]. In addition, BAG-1S and BAG-1L of mouse
origin are slightly smaller than the human isoforms.
BAG-1 was ﬁrst identiﬁed as a Bcl-2 binding partner with anti-
apoptotic properties [2]. BAG-1 downregulates apoptosis through
several mechanisms, and may play a role in progression of speciﬁc
cancers [3]. Therefore, many reports have focused on changes in
BAG-1 levels in cancerous tumors [4,5]. In parallel, BAG-1 has been
identiﬁed as a marker of neuronal differentiation and development
[6]. BAG-1 is highly expressed in developing neuronal tissue in the
prenatal mouse. In addition, overexpression of BAG-1 in neurons
can protect them from apoptosis following stress, such as gluta-
mate toxicity [7]. Therefore, it has been suggested that BAG-1
may play an anti-apoptotic function in neurons, similar to its role
in other tissues.
A central role for BAG-1 in the development of the nervous sys-
tem was validated when a BAG-1 / mouse was engineered [8].
The mouse died a few days after birth and showed a 50% decreasechemical Societies. Published by E
iott).in brain mass. The brain stained strongly for apoptotic markers,
and the neurons failed to develop into fully mature neurons. A
recent work has also determined that BAG-1 promotes axonal
regeneration in injured retinal ganglion cells in vitro [9]. Therefore,
BAG-1 is an important player in the generation and development of
neurons in the central nervous system.
Despite the plethora of work on endogenous BAG-1 in the
developing nervous system, there is little known about its role in
the function of the adult nervous system. This study examined
the expression and localization of BAG-1 in the adult mouse. A spe-
ciﬁc expression of BAG-1 was exhibited in proliferating neuronal
precursor cells (NPCs) found in the subventricular zone and the
dentate gyrus, as well as in migrating cells of the rostral migrating
stream. The speciﬁc expression of BAG-1 in NPCs led us to examine
its effect on these cells by lentiviral-mediated overexpression and
siRNA. BAG-1 overexpression had a pro-proliferatory effect on
NPCs in vitro. In addition, endogenous BAG-1 was found to be nec-
essary to partially attenuate the anti-proliferatory effect of gluco-
corticoids on these cells. In conclusion, BAG-1 functions in the
maintenance of NPCs in the mouse brain.2. Materials and methods
2.1. Brain homogenation and immunoblotting
C57BL/6 mice were anesthetized (ketamine) and decapitated.
Mice were provided by Harlan Laboratories and experiments were
approved by the Institutional Animal Use and Care Committeelsevier B.V. All rights reserved.
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homogenized in 10-times volume of Buffer H (20 mM HEPES, pH
7.4, 0.3 M sucrose, 1 mM EDTA, 0.1 mM benzamidine, 10 lg/ml
aprotinin, 10 lg/ml leupeptin, 5 lg/ml pepstatin, 1 mM phenyl-
methylsulfonyl ﬂuoride, 1 mM dithiothreitol) by 15 strokes in
glass-teﬂon homogenizer. Equal amounts of protein were loaded
on 10% SDS–PAGE and transferred to nitrocellulose membranes.
The membranes were blocked in non-fat milk for 2 h, incubated
with primary antibody overnight at 4 C, washed and then incu-
bated with horseradish peroxidase-conjugated secondary antibody
for 1 h. Membranes were then developed with enhanced chemilu-
minescence. Primary antibodies used include anti-BAG-1 (1:1000;
C-16, Santa Cruz Biotechnology), Tau-5 (1:10000), anti-Beta Actin
(1:20000; Sigma), anti-pERK (1:20000; kindly provided by Rony
Seger, Weizmann Institute of Science), anti-Hsp70 (1:1000; B-2,
Santa Cruz Biotechnology).
2.2. Nuclear and cytoplasmic fractionation
Brain homogenate prepared as described above were centri-
fuged at 1000  g for 10 min at 4 C. Supernatant was collected
as cytoplasmic fraction. Pellet was resuspended in 10 volumes
homogenation buffer, and then centrifuged again at same condi-
tions. Pellet was resuspended in homogenation buffer as nuclear
fraction and nuclear membranes were disrupted by adding a ﬁnal
concentration of 0.1% SDS. Both cytoplasmic and nuclear protein
concentrations were determined by Bradford, and equal amounts
of protein were loaded onto SDS–PAGE gel.
2.3. Immunohistochemistry
Brains from seven week old C57BL/6 mice were ﬁxed by intra-
cardial perfusion, and stored in 1.25% paraformaldehyde and 30%
sucrose at 4 C until sectioning. For sectioning, brains were frozen,
and sliced on a cryostat sliding microtome to 18 lm slices. Slices
were treated with 2M HCl at 37 C for 30 min, followed by a
10 min incubation in 50 mM borate buffer (pH 8.5). After blocking
the slices in 20% donor horse serum for 2 h, the slices were incu-
bated overnight in primary antibody in antibody buffer (2% donor
horse serum, 0.2% Tween, in PBS). Primary antibodies include anti-
Nestin (1:100; Chemicon), anti-BrdU (1:100; kindly provided by
Dr. Raya Eilam, Weizmann Institute of Science), anti-Doublecortin
(1:100; Dr. Raya Eilam), anti-BAG-1 (1:100; C-16, Santa Cruz Bio-
technology), and anti-NeuN (1:200; Dr. Raya Eilam). Slices were
then washed, reacted with dye-conjugated secondary antibody,
and incubated with Hoechst. Slices were then mounted on cover-
slides with moviol glue. The slices were visualized by ﬂuorescent
microscopy using 488 nm laser excitations for ﬂuorescein isothio-
cyanate and 545 nm for Cy3.
2.4. Proliferating neuronal precursor culture, and lysis
For each new primary culture, newborn C57BL/6 pups were
decapitated and brains were collected in PBS. After brief disassoci-
ation by pipetting, brains were incubated for 5 min with trypsin at
37 C. After brief centrifugation, pellet was resuspended in 1 ml
Neurocult proliferation medium (NPM) (Including Neurocult basal
medium and proliferation supplements; Stemcell Technologies,
Canada), and disaggregated with vigorous pipetting until a single
cell suspension was achieved. Cells were then plated in 25 ml of
NPM supplemented with 20 ng/ml EGF. Cells were cultured for
approximately 7 days. Medium containing ﬂoating neurospheres
were collected and centrifuged. Neurospheres were resuspended
in NPM, disaggregated with vigorous pipetting and replated for
an additional 4 days. After another two passages, cells were incu-
bated with virus concentration that had previously been deter-mined to result in 90–100% cells infected (.25 ll virus/ml
medium), as determined by GFP co-expression analysis. For lysis,
ﬂoating neurospheres were pelleted by centrifugation at 400 rpm
for 5 min. Cells were then incubated with lysis buffer (140 mM
KCL, 3 mM MgCl2, 1% Nonident P-40, 1% glycerol, 20 mM HEPES,
pH 7.4, protease inhibitors as described above) for 10 min at 4 C.
Immunoblotting was performed as described above.
2.5. Immunocytochemistry
Neurospheres were collected from medium by centrifugation at
400  g for 5 min. The neurospheres were then disassociated to a
single cell suspension by vigorous pipetting and plated on
12 mm coverslides precoated with Poly-L-orthinine (50 micro-
gram/ml). In some experiments, BrdU (1 lM) was added 4 h after
plating. Sixteen hours following plating, cells were ﬁxed with 4%
paraformaldehyde in 4% sucrose for 20 min at room temperature.
After permeabilization with 0.3% Triton X-100 for 3 min and block-
ing with 10% goat serum in PBS, the slides were incubated with pri-
mary antibodies overnight at room temperature. Primary
antibodies include anti-Nestin (1:100; Chemicon), anti-BrdU
(1:100; kindly provided by Dr. Raya Eilam, Weizmann Institute of
Science), and anti-Doublecortin (1:100; Dr. Raya Eilam). Slides
were then washed, reacted with a secondary antibody conjugated
to CY3. The cells were then incubated with Hoechst solution for
3 min, and then mounted on slides. The slices were visualized by
ﬂuorescent microscopy using 488 nm laser excitations for GFP
and 545 nm for Cy3.
2.6. Virus production and infection
Viruses were produced and packaged by transfection of viral
producing plasmids in 293-HEK cells. The appropriate plasmids
were kindly provided by Dr. Alon Chen (Weizmann Institute of Sci-
ence, Israel). The pCSC expression plasmid containing cDNA over-
expressing BAG-1 was co-transfected with pMDL, pRSV-Rev, and
VSV-G plasmids in 12 conﬂuent 150 mm tissue culture plates using
the PEI protocol. The plates were washed the following day and
then virus containing medium was collected the following 2 days.
The viral particles were concentrated by centrifugation at
53000  g for 2.5 h, and resuspended in Hank’s Buffered Saline
Solution and stored at 80 C. Virus titer was determined by infec-
tion of 293 cells. For infections, viral particles were added to med-
ium of proliferating neuronal precursors.
2.7. BrdU injections of mice
6 month old C57BL/6 mice were injected i.p. with 50 mg/kg
BrdU every 12 h for 2 days, and then perfused the following day.
2.8. Plasmids
All lentiviral expression vectors were a kind gift from Dr. Alon
Chen (Weizmann Institute of Science, Israel). BAG-1 was inserted
into pCSC-SP lentiviral expression construct in the BamH1 site of
the Multiple Cloning Site. pCSC-SP expression construct without
BamH1 insert was used in control virus. For BAG-1 siRNA, the siR-
NA sequence was inserted into the p156RRL siRNA expression con-
struct. The sequence used was 50-GGGCAACTAGCCAAATGTC-30
[8,10].
2.9. Statistics
Western blots were quantiﬁed by NIH imager software. Statisti-
cally signiﬁcant differences between mean values were deter-
mined using unpaired Student’s t-test. S.E. bars are provided. P
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ﬁgure legend.
3. Results
To evaluate the levels of BAG-1 protein in the brain during
mouse development and maturation, we analyzed brain homoge-
nate using Western Blot. Protein levels of both BAG-1L (p50) and
BAG-1S (p29) isoforms decreased during mice development
(Fig. 1). However, the pattern of this decrease was different be-
tween the two isoforms. BAG-1L levels decreased signiﬁcantly be-
tween E15 and 1 week postnatal, while BAG-1S levels declined
suddenly between 1 and 7 weeks postnatal. In additional experi-
ments, mice brains were fractionized into cytoplasmic and nuclear
fractions using centrifugation. BAG-1S was the dominant isoform
in both fractions at E15, while BAG-1L and BAG-1S levels were
nearly equal in the nuclear fraction at stages of full development.
However, both isoforms decreased in both fractions during mouse
development. In conclusion, BAG-1 has a higher expression in the
early development of the brain than in the adult brain.
To determine where BAG-1 is expressed in the adult mouse
brain, sections were analyzed using immunohistochemistry. An
antibody targeting BAG-1 revealed some low levels of ubiquitous
staining in the hippocampus and cortex (data not shown). How-
ever, the most intense staining was visualized in the subventricular
zone (SVZ), which borders the lateral ventricles (Fig. 2A and B).
This zone is a niche for proliferating neuronal precursors, which
subsequently migrate to the olfactory bulb and differentiate into
fully functioning neurons of the olfactory system. Using BrdU
incorporation as a marker for proliferating cells, we see that
BAG-1 is highly expressed in the niche of cells that are proliferatingFig. 1. BAG-1 expression during brain development. (A) BAG-1 levels in the brain were an
to verify equal protein levels. Tau isoforms change according to stages in mouse devel
represented as mean ± S.E. (n = 3; *P < 0.02, **P < 0.01). (C) Brains from mice at different d
amounts of protein were loaded on SDS–PAGE gel and analyzed by Western blot with
(cytoplasmic marker).(Fig. 2A). To verify that these cells are neuronal precursors, we
stained with an antibody targeting Nestin, a cytosolic marker of
NPCs. BAG-1 and Nestin were found in the same cell population
(Fig. 2B). Analysis of the SVZ with confocal microscopy showed
that BAG-1 is found in the nuclei of Nestin expressing cells
(Fig. 2C). Therefore, BAG-1 is expressed in the nucleus of NPCs.
The one other site of NPCs in the brain, the dentate gyrus, was
also analyzed for BAG-1 expression. Cells (84%) that stained posi-
tive for BrdU incorporation also stained positive for BAG-1 while
only 27% of the BrdU negative cells stained positive for BAG-1
(Fig. 2D and E). Therefore, BAG-1 is found at relatively high levels
in proliferating cells in both brain regions with proliferating neuro-
nal precursors.
The abundant expression of BAG-1 among proliferating neuro-
nal precursors was veriﬁed by Western blot analysis. Neuro-
spheres, containing proliferating neuronal precursors, were
cultured from newborn mice using standard protocols. Protein ex-
tract from the neurospheres were compared to extracts from total
newborn mouse brain. The amounts of both BAG-1 isoforms were
signiﬁcantly higher in the cultured neuronal precursors than in the
total brain extract (Fig. 2F). In addition, lysates from neurospheres
were fractionated into nuclear and cytoplasmic fractions, and ana-
lyzed by Western blot. Both isoforms of BAG-1 were localized
mainly in the nuclear fraction (Fig. 2G). These biochemical experi-
ments corroborate well with the microscopy data to show that
BAG-1 is highly expressed in neuronal precursor cells, and localizes
mainly to the nucleus.
After initiating the process of differentiation to a neuronal phe-
notype, neuronal precursors from the SVZ migrate to the olfactory
bulb through a deﬁned pathway called the rostral migratory
stream [11]. These cells, which do not yet have a fully neuronalalyzed during mouse development by Western blot. Beta Actin levels are visualized
opment. (B) Quantiﬁcation of the data from Fig. 1A using NIH imager. Results are
evelopmental times were fractionated into nuclear and cytoplasmic fractions. Equal
antibodies targeting BAG-1, splicing factor 2 (SF2; a nuclear marker), and tubulin
Fig. 2. BAG-1 expression in niches of neuronal precursor proliferation. (A–D) Mouse brain slices (18 lm) from BrdU injected mice were analyzed by immunohistochemistry
with primary antibodies targeting BAG-1 and BrdU (A and D), or nestin (B andC).. The subventricular zone (A–C) and dentate gyrus (D) were examined by ﬂuorescent
microscopy. Scale bar sizes are 500 lm(A), 50 lm(B), 10 lm(C), and 50 lm(D). (E) Quantitative analysis of BrdU+ compared to BAG-1+ cells in the dentate gyrus. Results are
represented as means ± S.E. (*P < 0.01). Ten sections were analyzed from three mice for a total of 30 sections analyzed. All cells in the ﬁeld were analyzed. (F) Total brain and
NCS cultures (neurospheres) were analyzed by Western blot. BAG-1 levels are higher in neurosphere (labeled NS) lysate than in total brain homogenate. (G) Neurosphere
lysate was separated into nuclear and cytoplasmic fractions, and analyzed by Western blot. Both BAG-1 isoforms are primarily in nuclear fraction.
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tin. We determined if migrating cells retain the high BAG-1 expres-
sion by co-immunohistochemistry. The cells migrating from the
SVZ to the olfactory bulb retained high expression of BAG-1, as
seen by costaining with antibodies targeting doublecortin and
BAG-1 (Fig. 3A). Coronal sections of olfactory bulb tissue also re-
vealed high levels of BAG-1 staining in migrating cells expressing
doublecortin (Fig. 3B). Surrounding cells that no longer express
doublecortin lost the BAG-1 expression. Confocal microscopy anal-
ysis shows that BAG-1 was usually visualized in the nuclei, while
the doublecortin was in the cytoplasm (Fig. 3C). Staining of olfac-
tory bulb for the neuronal marker NeuN also shows that NeuN
expressing cells exhibit less BAG-1 staining (Fig. 3D). Therefore,
BAG-1 expression was maintained through proliferatory and
migratory stages, but then downregulated by full maturation.
To analyze the role of BAG-1 in proliferating cells, we engi-
neered lentiviral vectors that express the cDNA for the human
BAG-1 gene, as well as a vector that expresses siRNA that targets
the BAG-1 gene. Viral particles containing these vectors, or a con-
trol vector, were infected into cultures of proliferating neuronal
precursors. At least 90% of cells were infected as judged by co-
expression of the marker protein GFP (not shown). Infection with
viral particles expressing siRNA led to a decrease in approximately
80% of BAG-1 levels (n = 4, P = 0.002163). The siRNA targets all
BAG-1 isoforms because they are translated from the same mRNA.
Infection with viral particles overexpressing human BAG-1 led to
an increase in BAG-1 levels. Extra bands seen on the Western blot
analysis are due to the fact that human BAG-1L and BAG-1S run
slightly higher on an SDS–PAGE gel, and human BAG-1M runs at
the same weight as mouse BAG-1L [1] (Fig. 4A). After 3 days of
incubation with the virus, a signiﬁcantly higher amount of neuro-
spheres were present in the cultures overexpressing BAG-1(Fig. 4B). This suggests a higher rate of growth in precursors over-
expressing BAG-1. However, downregulation of BAG-1 had no ef-
fect on neurosphere formation. To further study proliferation, we
incubated infected cells with BrdU for 12 h, and detected BrdU
incorporation with immunocytochemistry. A signiﬁcantly higher
percentage of BAG-1 overexpressing cells were labeled with BrdU
compared to control and BAG-1 underexpressing cells (Fig. 4C
and D). Nestin, a marker for NPCs, labeled all cells under all condi-
tions, suggesting that manipulation of BAG-1 did not affect the
cell’s status (Fig. 4C). In addition, BAG-1 overexpression or down-
regulation didn’t induce expression of the neuronal marker pro-
teins doublecortin or tau (data not shown). Since BAG-1 may
affect pERK activation under certain conditions, we checked pERK
levels in infected cells. There were no changes in pERK levels, sug-
gesting that activation of the pERK pathway is not responsible for
the increase of NPC proliferation (Fig. 4A). These experiments indi-
cate that BAG-1 can increase the proliferation rate of neuronal pre-
cursors, but basal levels may not be necessary to maintain the
basal proliferation rate.
Neuronal precursor proliferation can be downregulated by
stress signals, including glucocorticoids, such as corticosterone
[12]. It has been shown that BAG-1 is a binding partner for gluco-
corticoid receptors, and can attenuate their activity [13]. Therefore,
we tested if BAG-1 can regulate the effect of corticosterone on neu-
ronal proliferation by treating viral infected cells with corticoste-
rone. Corticosterone treatment reduced the number of
neurospheres in culture by 18%. However, corticosterone together
with siRNA led to a 33% decrease in total neurosphere number. In
contrast, BAG-1 overexpression attenuated the effect of corticoste-
rone on neurosphere formation (Fig. 5A). We also used the BrdU
incorporation assay to explore the effect of BAG-1 and corticoste-
rone on proliferation. Similarly, BAG-1 underexpression strength-
Fig. 3. BAG-1 expression in migrating neuronal precursors. (A) Sagittal slices of mouse brain were immunostained for BAG-1, and for doublecortin to visualize the migrating
neuronal precursors in the rostral migratory stream. (B and C) Coronal section of mouse olfactory bulb was immunostained for BAG-1 and for doublecortin (DCX). White
arrows show a portion of the cells containing both BAG-1 and doublecortin. BAG-1 is mainly nuclear. (D) Coronal section of mouse olfactory bulb immunostained for BAG-1
and for NeuN, a nuclear marker of mature neurons. Scale bar sizes are 250 lm (A), 50 lm (B) 10 lm (C) , and 100 lm (D). Phase contrast overview of the sections are provided
for A, B, and D. Picture from C is taken from area adjacent to area visualized in B. LV, lateral ventricle, OB, olfactory bulb, Gl, glomeruli, M, mitral body layer, Gr, granule cell
layer.
Fig. 4. BAG-1 overexpression increases proliferation rates of NPCs. (A) Neuronal precursor cell cultures were infected with lentiviruses containing empty vector, siRNA
targeting BAG-1, or cDNA overexpressing BAG-1 (BAG-1 OE). Western blot analysis shows the levels of BAG-1 after infection. (B) Infected NPCs were grown in culture for four
days, and then total neurospheres formed were counted from each culture (n = 5, *P < 0.01). (C) Neuronal precursor cells infected with viruses were incubated with BrdU for
12 h, and then immunostained for BrdU and the neuronal precursor marker Nestin. (D) Statistical analysis of BrdU+ cells from Fig. 4C (n = 5, *P < 0.01).
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Fig. 5. BAG-1 regulates response of NPCs to corticosterone. (A) Infected NPCs were grown in culture ± corticosterone (1 lM) for 4 days, and then total neurospheres in culture
were counted (n = 5, *P < 0.01). (B) Infected NPCs were grown in culture ± corticosterone, incubated with BrdU for 12 h, and then subjected to immunocytochemistry to
determine BrdU incorporation (n = 5, *P < 0.01).
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BAG-1 overexpression abolished the effect (Fig. 5B). Therefore,
endogenous BAG-1 is necessary to buffer the effect of corticoste-
rone on proliferating cells, and BAG-1 overexpression can com-
pletely attenuate the effect.4. Discussion
BAG-1 has been implicated in processes of neuronal develop-
ment. Until now, there has been little study on the role of endoge-
nous BAG-1 in the brain after development. The data from this
work suggest that BAG-1 maintains its role as a factor in neuronal
development and neurogenesis in the adult mouse brain. BAG-1 is
found in relatively high levels in NPCs in both niches of adult neu-
rogenesis, the subventricular zone and dentate gyrus. In addition,
the overall decrease in BAG-1 levels after mouse development fur-
ther suggests that the main role of BAG-1 in the brain is develop-
mental, and may play only more minor roles in the mature
neurons. This is further supported by our ﬁndings that BAG-1 is
downregulated in the olfactory neurons during the same develop-
mental timepoint that NeuN is expressed.
Using lentiviral mediated depletion and overexpression of BAG-
1 in NPCs, we determined that an overexpression of BAG-1 in-
creases the proliferation rate of NPCs in vitro. This correlates well
with an established pro-proliferation function of BAG-1 in other
cell types. However, siRNA depletion had no effect on proliferation
rates. We hypothesized that endogenous BAG-1 may be necessary
to protect NPCs from stress signals, such as glucocorticoids, that
are not found normally in the cell culture medium. BAG-1 had pre-
viously been shown to inhibit the glucocorticoid receptor in neuro-
nal cells. Therefore, we determined the effects of depletion and
overexpression of BAG-1 in the presence of corticosterone, a mem-
ber of the glucocorticoid family. RNAi depletion of BAG-1 induced a
decrease of proliferation in the presence of corticosterone, com-
pared to corticosterone treatment alone. Therefore, endogenous
BAG-1 is necessary to partially attenuate the effects of glucocorti-
coids on NPC proliferation.
Earlier research has suggested that BAG-1 may induce neuronal
differentiation through interactions with Raf-1. In our studies,
BAG-1 overexpression did not induce a neuronal phenotype of
NPCs, but rather affected cell proliferation. We also note that Nes-
tin staining, a marker for undifferentiated NPCs, did not change
after BAG-1 overexpression. However, the continued expression
of BAG-1 in the migrating cells of the rostral migratory stream
(Fig. 2) suggests that BAG-1may also play important roles in differ-
entiating cells.Transgenic mice overexpressing BAG-1 in neurons are less sus-
ceptible to glutamate toxicity [7] and are able to recover quickly
from manic-like and depressive-like behaviors, compared to con-
trol mice [14]. Therefore, replenishing the BAG-1 levels in mature
neurons may have some positive behavioral effects. However,
BAG-1 has also been shown to increase intracellular levels of tau
protein [10], which is an important protein leading to Alzheimer’s
Disease pathology. Therefore, the decrease in BAG-1 levels upon
maturation may be necessary to prevent tau accumulation.
In summary, we report a decrease in brain BAG-1 expression
during mouse development, and a preferential expression of BAG-
1 in NPCs in the adult brain. BAG-1 overexpression by lentiviral
infection induced an increase in NPC proliferation in vitro. Deple-
tion of BAG-1 by siRNA induced a decrease of NPC proliferation in
the presence of corticosterone. Therefore, a major role for BAG-1
in the adult mouse brain is the continued maintenance of NPCs.
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